Live Quote · NASDAQBYSIHealthcare· Biotechnology

BeyondSpring Inc.

$1.87 1.08%(+$0.02)
TickerSpark Score
58/100
Mixed
60
Valuation
40
Profitability
60
Growth
52
Health
80
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BYSI research report →

52-Week Range55% of range
Low
$1.18
Current
$1.87
High
$2.44

About the company

BeyondSpring Inc. is a clinical-stage biopharmaceutical company focused on developing novel cancer treatments. Its flagship product is Plinabulin, a selective immune-modulating and microtubule-binding agent.

CEO
Lan Huang
IPO
2017
Employees
40
HQ
Florham Park, NY, US

Price Chart

-18.34% · this period
$2.35$1.81$1.27Jul 02Dec 31Jul 02
Valuation
Market Cap
$76.89M
P/E
-10.06
P/S
0.00
P/B
-2.23
EV/EBITDA
-9.12
Div Yield
0.00%
Profitability
Gross Margin
0.00%
Op Margin
0.00%
Net Margin
0.00%
ROE
23.76%
ROIC
-136.37%
Growth & Income
Revenue
$0 · 0.00%
Net Income
$-7,992,000 · 28.15%
EPS
$-0.20 · 28.57%
Op Income
$-8,945,000
FCF YoY
-20.44%
Performance & Tape
52W High
$2.44
52W Low
$1.18
50D MA
$1.59
200D MA
$1.70
Beta
0.42
Avg Volume
19.82K

Get TickerSpark's AI analysis on BYSI

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Mar 20, 26Huang Lanother260,582
Apr 1, 26Kirkby Matthewother23,902
Apr 1, 26Fabbio Patrickother22,165
Apr 1, 26Delaney Brendanother20,427
Apr 1, 26Majeti Jiangwenother21,730
Apr 1, 26Lu Yingjuan Juneother17,840
Apr 1, 26Huang Lanother11,514
Apr 1, 26Xu Sihaiother18,689
Oct 16, 25Decheng Capital China Life Sciences USD Fund III, L.P.sell85,798
Oct 17, 25Decheng Capital China Life Sciences USD Fund III, L.P.sell45,513
Coverage · BYSI

Our BYSI coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on BYSI yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate BYSI report →
Internal Compare

Similar companies

Peers in the same neighborhood.